M6P-modified solid lipid nanoparticles loaded with matrine for the treatment of fibrotic liver.

导出 OA

翻译打印收藏纠错

第一作者： Xiaochuan,Tan

第一单位： Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

作者： Xiaochuan,Tan ^[1] ; Yumei,Hao ^[1] ; Nai,Ma ^[1] ; Yige,Yang ^[1] ; Wenzhen,Jin ^[1] ; Ya,Meng ^[1] ; Chuchu,Zhou ^[1] ; Wensheng,Zheng ^[1] ; Yujia,Zhang ^[1]

作者单位： Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. ^[1]

关键词 Liver fibrosis M6P-HSA-MT-SLN matrine target delivery

主题词人类(Humans);肝硬化(Liver Cirrhosis);脂质体(Liposomes);纳米粒子(Nanoparticles)

DOI 10.1080/10717544.2023.2219432

PMID 37300371

发布时间 2023-06-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交